-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MmdcT1OvBRcDClzS59tR4w0+EoikOpMXRatCzKUpoMLQt2QXuu0NXngQJLguNjsd hoXgHciSAVWERxllpRDTuw== 0000897101-97-000648.txt : 19970605 0000897101-97-000648.hdr.sgml : 19970605 ACCESSION NUMBER: 0000897101-97-000648 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970604 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANGEION CORP/MN CENTRAL INDEX KEY: 0000815093 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411579150 STATE OF INCORPORATION: MN FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40187 FILM NUMBER: 97619106 BUSINESS ADDRESS: STREET 1: 3650 ANNAPOLIS LN STREET 2: STE 170 CITY: MINNEAPOLIS STATE: MN ZIP: 55447-5434 BUSINESS PHONE: 6125509388 MAIL ADDRESS: STREET 1: 3650 ANNAPOLIS LANE STREET 2: SUITE 170 CITY: PLYMOUTH STATE: MN ZIP: 55447-5434 FORMER COMPANY: FORMER CONFORMED NAME: VERDE VENTURES INC DATE OF NAME CHANGE: 19880714 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PACESETTER INC CENTRAL INDEX KEY: 0000931326 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 15900 VALLEY VEIW COURT CITY: SYLMAR STATE: CA ZIP: 91392-9221 BUSINESS PHONE: 6124832000 MAIL ADDRESS: STREET 1: 15900 VALLEY VIEW COURT CITY: SYL,AR STATE: CA ZIP: 91392-9221 SC 13D/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* ANGEION CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 03462H10 (CUSIP Number) Kevin T. O'Malley Kevin T. O'Malley Vice President and Secretary Vice President and General Counsel Pacesetter, Inc. St. Jude Medical, Inc. 15900 Valley View Court One Lillehei Plaza Sylmar, CA 91392-9221 St. Paul, MN 55117 Telephone: (612)483-2000 Telephone: (612) 483-2000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 30, 1997 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box. NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages - ----------------------------------- CUSIP No. 03462H10 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS PACESETTER, INC. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [x] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See instructions) AF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 0 SHARES ------------------------------------------------------ BENEFICIALLY 8 SHARED VOTING POWER 1,125,000 OWNED BY ------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------ PERSON 10 SHARED DISPOSITIVE POWER 1,125,000 WITH - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,125,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] (See instructions) - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.91% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See instructions) CO - -------------------------------------------------------------------------------- Page 2 of 5 Pages - -------------------------------------------- CUSIP No. 03462H10 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS ST. JUDE MEDICAL, INC. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [x] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See instructions) WC; BK - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION MINNESOTA - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 0 SHARES ------------------------------------------------------ BENEFICIALLY 8 SHARED VOTING POWER 1,125,000 OWNED BY ------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING ------------------------------------------------------ PERSON 10 SHARED DISPOSITIVE POWER 1,125,000 WITH - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,125,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] (See instructions) - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.91% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See instructions) CO - -------------------------------------------------------------------------------- Page 3 of 5 Pages Item 1. Security and Issuer. The class of equity securities to which this Amendment No. 1 to Schedule 13D relates is the common stock, par value $.01 per share (the Common Stock ) of Angeion Corporation ( Angeion ), a Minnesota corporation, with its principal executive offices located at 3560 Annapolis Lane, Suite 170, Minneapolis, Minnesota 55447-5434. Item 4. Purpose of Transaction. Pacesetter, Inc. ( Pacesetter ), a Delaware corporation, is a wholly owned subsidiary of St. Jude Medical, Inc. ( SJM ), a Minnesota corporation. Pacesetter is no longer the beneficial owner of greater than 5% of the outstanding capital stock of Angeion Corporation. The reduction of the percentage ownership of Pacesetter resulted from an increase in the outstanding Common Stock of Angeion Corporation. The Schedule 13D of Pacesetter and SJM dated October 7, 1994 is hereby terminated. Page 4 of 5 Pages Signatures After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: May 30, 1997 PACESETTER, INC. By /s/ Kevin T. O'Malley ---------------------------------- Kevin T. O'Malley Vice President and Secretary ST. JUDE MEDICAL, INC. By /s/ Kevin T. O'Malley ---------------------------------- Kevin T. O'Malley Vice President and General Counsel Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----